Oxysterols, Atherosclerosis and Metabolic Syndrome
氧甾醇、动脉粥样硬化和代谢综合征
基本信息
- 批准号:7622658
- 负责人:
- 金额:$ 37.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AffectAneurysmAngiotensinsArterial Fatty StreakAtherosclerosisBiologicalBiological MarkersBiologyBiometryBlood PressureBlood VesselsBody Weight decreasedCalciumCardiologyCardiovascular DiseasesCardiovascular systemCaringCarotid ArteriesCentral obesityCholesterolClinical TrialsCoronary heart diseaseCritical PathwaysDataDetectionDevelopmentDiabetes MellitusDietDiseaseDisease regressionDoctor of PhilosophyDyslipidemiasEndocrinologistEvaluationExhibitsFacultyFatty acid glycerol estersFunctional disorderGelatinase BGenesGeneticGenetic MarkersGenetic PolymorphismGenotypeGlucoseGlucose IntoleranceHeart ValvesHepaticHigh Density LipoproteinsHomeostasisHumanHyperandrogenismHyperglycemiaHyperinsulinismHyperlipidemiaHypertensionHypertrophyImageImaging TechniquesIndiumIndividualInflammatoryInflammatory ResponseInsulin ResistanceInterventionLesionLipidsLipoproteinsMeasurementMeasuresMechanicsMediatingMediator of activation proteinMetabolicMetabolic syndromeMetabolismMineralsModelingMolecularMorbidity - disease rateMusNADPNecrosisNuclear ReceptorsNumbersObesityPathologicPathway interactionsPatientsPhenotypePlasmaPlayPolycystic Ovary SyndromeProductionProtein OverexpressionRegulationReproducibilityResearchResearch PersonnelResistanceRiskRisk FactorsRoleSerumSideSiteSmooth Muscle MyocytesSterolsStimulusStructureStudy modelsSupraoptic Vertical OphthalmoplegiaTestingThickTimeTissuesTransactivationTranscription Factor AP-1Transgenic MiceTriglyceridesTunica AdventitiaUSF1 geneUltrasonographyUniversitiesUp-RegulationVascular DiseasesVascular calcificationVascular remodelingWashingtonWeight GainWomanWorkage relatedatherogenesisbench to bedsidebonecalcificationcell motilityclaycoronary artery calcificationcytokinecytotoxicitydiabeticfeedinggenetic epidemiologygenetic variantglucose metabolismintima medialipid metabolismloss of functionmacrophagemedical schoolsmembermortalitymultidisciplinaryneutralizing antibodynormal agingnovelosteopontinoxidized lipidparacrineprogramspromoterradiologistresponsetranscription factor USFtranslational studyuptakevascular smooth muscle cell proliferation
项目摘要
Atheroclerosis is a major cause of morbidity and mortality in insulin-resistant states such as metabolic
syndrome and obesity. Defective regulation of macrophage lipid metabolism plays a central role in the
development of vascular lesions associated with these dyslipidemic states. During atherogenesis,
macrophages respond to the challenge of lipid excess through enzymatic production of oxysterols and
activation of feed-forward nuclear receptor pathways that induce transcriptional programs involved in lipid
uptake and efflux, and negatively regulate inflammatory responses. In recent studies, we have shown that
the products of the Niemann-Pick type C (NPC) disease genes, NPC1 and NPC2, are required for delivery of
lipoprotein-derived cholesterol to sites of intracellular oxysterol synthesis. In this proposal, we will test the
hypothesis that macrophage-derived oxysterols play a critical role in the regulation of lipid
homeostasis in the vascular wall. We propose that impaired synthesis of side-chain oxygenated sterols
will reduce cholesterol efflux and increase cholesterol accumulation in macrophages, and, in concert with
increased levels of oxidized cholesterol, promote cytotoxicity and lesion formation. Production of specific
macrophage-derived cholesterol metabolites additionally may play a critical role in governing plasma
lipoprotein levels through regulation of hepatic lipoprotein synthesis and/or clearance of plasma lipoproteins.
This hypothesis will be tested by the following specific aims:
1) To determine whether macrophage-specific NPC1 and NPC2 loss of function alters macrophage oxysterol
synthesis, thereby disrupting lipid homeostasis and promoting atherosclerosis in a murine model,
2) To determine whether macrophage-derived cholesterol metabolites affect regulation of plasma lipoprotein
levels in chimeric mice with macrophage-specific NPC1 and NPC2 loss of function, and
3) To assess the relationship between plasma oxysterol levels and coronary heart disease and determine if
oxysterol levels change following weight loss in humans with the metabolic syndrome.
These studies will contribute to our understanding of the role of macrophage-derived cholesterol
metabolites in atherogenesis and regulation of lipoprotein metabolism. This project has the potential to
transform the care of people with the metabolic syndrome by establishing these metabolites as novel
biomarkers for detection of subclinical atherosclerotic disease.
动脉粥样硬化是胰岛素抵抗状态(例如代谢)发病率和死亡率的主要原因
综合征和肥胖。巨噬细胞脂质代谢有缺陷在
与这些血脂症状相关的血管病变的发展。在动脉粥样硬化期间,
巨噬细胞通过酶促产生氧甲醇和
激活前馈核受体途径,诱导参与脂质的转录程序
吸收和排出,并对炎症反应负面调节。在最近的研究中,我们表明
Niemann-Pick型C(NPC)疾病基因,NPC1和NPC2的产物是递送所必需的
脂蛋白衍生的胆固醇与细胞内氧蛋白酶合成部位。在此提案中,我们将测试
假设巨噬细胞衍生的氧甲醇在调节脂质中起关键作用
血管墙中的稳态。我们提出侧链氧化固醇的合成受损
将减少胆固醇外排并增加巨噬细胞中的胆固醇积累,并与
氧化胆固醇水平增加,促进细胞毒性和病变形成。特定的生产
巨噬细胞衍生的胆固醇代谢产物还可能在治理血浆中起关键作用
脂蛋白水平通过调节肝脂蛋白合成和/或血浆脂蛋白清除率。
该假设将通过以下特定目的进行检验:
1)确定巨噬细胞特异性的NPC1和NPC2功能的损失是否改变了巨噬细胞甲醇
合成,从而破坏脂质稳态并促进鼠模型中的动脉粥样硬化,
2)确定巨噬细胞衍生的胆固醇代谢物是否影响血浆脂蛋白的调节
具有巨噬细胞特异性NPC1和NPC2功能丧失的嵌合小鼠的水平,并且
3)评估血浆氧蛋白酶水平与冠状动脉疾病之间的关系,并确定是否
代谢综合征的人类体重减轻后,氧蛋白酶水平发生了变化。
这些研究将有助于我们理解巨噬细胞衍生的胆固醇的作用
脂蛋白代谢的动脉粥样硬化和调节中的代谢产物。这个项目有可能
通过建立这些代谢物作为新颖的人来改变人们的护理
检测亚临床动脉粥样硬化疾病的生物标志物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL S ORY其他文献
DANIEL S ORY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL S ORY', 18)}}的其他基金
OXYSTEROL BIOMARKERS FOR NIEMANN-PICK C DISEASE
尼曼-皮克 C 病的氧甾醇生物标志物
- 批准号:
9069134 - 财政年份:2013
- 资助金额:
$ 37.38万 - 项目类别:
OXYSTEROL BIOMARKERS FOR NIEMANN-PICK C DISEASE
尼曼-皮克 C 病的氧甾醇生物标志物
- 批准号:
8658869 - 财政年份:2013
- 资助金额:
$ 37.38万 - 项目类别:
OXYSTEROL BIOMARKERS FOR NIEMANN-PICK C DISEASE
尼曼-匹克 C 病的氧甾醇生物标志物
- 批准号:
9281925 - 财政年份:2013
- 资助金额:
$ 37.38万 - 项目类别:
OXYSTEROL BIOMARKERS FOR NIEMANN-PICK C DISEASE
尼曼-皮克 C 病的氧甾醇生物标志物
- 批准号:
8593643 - 财政年份:2013
- 资助金额:
$ 37.38万 - 项目类别:
REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS
非编码 RNA 调节胆固醇稳态
- 批准号:
7912069 - 财政年份:2010
- 资助金额:
$ 37.38万 - 项目类别:
REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS
非编码 RNA 调节胆固醇稳态
- 批准号:
8444326 - 财政年份:2010
- 资助金额:
$ 37.38万 - 项目类别:
REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS
非编码 RNA 调节胆固醇稳态
- 批准号:
8274949 - 财政年份:2010
- 资助金额:
$ 37.38万 - 项目类别:
REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS
非编码 RNA 调节胆固醇稳态
- 批准号:
8095515 - 财政年份:2010
- 资助金额:
$ 37.38万 - 项目类别:
REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS
非编码 RNA 调节胆固醇稳态
- 批准号:
8049125 - 财政年份:2010
- 资助金额:
$ 37.38万 - 项目类别:
REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS
非编码 RNA 调节胆固醇稳态
- 批准号:
8225176 - 财政年份:2010
- 资助金额:
$ 37.38万 - 项目类别:
相似国自然基金
Osteoglycin在主动脉瘤发生发展中的作用和机制研究
- 批准号:81900414
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
AT1受体自身抗体通过增强AT1受体敏感性加重腹主动脉瘤的作用及机制研究
- 批准号:81900415
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
Ang-(1-7)在腹主动脉瘤发生发展中的作用及机制研究
- 批准号:81800409
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
纳米疫苗ATRQβ-001防治腹主动脉瘤的机制研究
- 批准号:81600390
- 批准年份:2016
- 资助金额:17.5 万元
- 项目类别:青年科学基金项目
内皮GCH1在腹主动脉瘤形成中的作用以及作为治疗靶目标的意义
- 批准号:81571376
- 批准年份:2015
- 资助金额:25.0 万元
- 项目类别:面上项目
相似海外基金
Role of senescent cells in the pathogenesis of Marfan-associated cardiovascular disease
衰老细胞在马凡相关心血管疾病发病机制中的作用
- 批准号:
10112292 - 财政年份:2018
- 资助金额:
$ 37.38万 - 项目类别:
Role of senescent cells in the pathogenesis of Marfan-associated cardiovascular disease
衰老细胞在马凡相关心血管疾病发病机制中的作用
- 批准号:
9889168 - 财政年份:2018
- 资助金额:
$ 37.38万 - 项目类别:
Intrinsic Stiffness of Aortic Vascular Smooth Muscle Cell in the Development of Hypertension
高血压发展过程中主动脉血管平滑肌细胞的固有硬度
- 批准号:
8959886 - 财政年份:2013
- 资助金额:
$ 37.38万 - 项目类别: